Literature DB >> 17434405

Autosomal dominant polycystic kidney disease.

Vicente E Torres1, Peter C Harris2, Yves Pirson3.   

Abstract

Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes. An increased understanding of the disorder's underlying genetic, molecular, and cellular mechanisms and a better appreciation of its progression and systemic manifestations have laid out the foundation for the development of clinical trials and potentially effective treatments.

Entities:  

Mesh:

Year:  2007        PMID: 17434405     DOI: 10.1016/S0140-6736(07)60601-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  482 in total

1.  The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease.

Authors:  Xiaoying Lian; Xiaoyuan Wu; Zhongxin Li; Yingjie Zhang; Kangkang Song; Guangyan Cai; Qinggang Li; Shupeng Lin; Xiangmei Chen; Xue-Yuan Bai
Journal:  Br J Pharmacol       Date:  2019-01-10       Impact factor: 8.739

2.  Development of Severe Hyperparathyroidism Despite Short-Term Renal Replacement Therapy.

Authors:  Manabu Okada; Yoshihiro Tominaga; Takahisa Hiramitsu; Toshihiro Ichimori
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Altered trafficking and stability of polycystins underlie polycystic kidney disease.

Authors:  Yiqiang Cai; Sorin V Fedeles; Ke Dong; Georgia Anyatonwu; Tamehito Onoe; Michihiro Mitobe; Jian-Dong Gao; Dayne Okuhara; Xin Tian; Anna-Rachel Gallagher; Zhangui Tang; Xiaoli Xie; Maria D Lalioti; Ann-Hwee Lee; Barbara E Ehrlich; Stefan Somlo
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

4.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

5.  Telling kidneys to cease and decyst.

Authors:  Vinita Takiar; Michael J Caplan
Journal:  Nat Med       Date:  2010-07       Impact factor: 53.440

6.  Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium.

Authors:  Tengis S Pavlov; Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Oleh Pochynyuk; Alexander Staruschenko
Journal:  J Vis Exp       Date:  2015-09-01       Impact factor: 1.355

Review 7.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

8.  Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Antonio Concistrè; Luigi Petramala; Gianmarco Scoccia; Susanna Sciomer; Valeria Bisogni; Vincenza Saracino; Gino Iannucci; Silvia Lai; Daniela Mastroluca; Gianluca Iacobellis; Claudio Letizia
Journal:  Cardiorenal Med       Date:  2018-05-03       Impact factor: 2.041

9.  Somatic second-hit mutations leads to polycystic liver diseases.

Authors:  Jesús M Banales; Patricia Munoz-Garrido; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

10.  Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+]i homeostasis in human autosomal-dominant polycystic kidney disease cells.

Authors:  Viktor Tomilin; Gail A Reif; Oleg Zaika; Darren P Wallace; Oleh Pochynyuk
Journal:  FASEB J       Date:  2018-03-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.